Bora CDMO Bora CDMO

X

Find the latest Drugs in Development and Pipeline Prospector News of Innocoll Pharmaceuticals Limited.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Innocoll Pharmaceuticals Limited
Ireland Flag
Country
Country
Ireland
Address
Address
Unit 9, Block D, Monksland Business Park, Monksland, Athlone, Co. Roscommon
Telephone
Telephone
+353 (0) 90 6486834

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Details:

POSIMIR® (bupivacaine solution) for infiltration use reduced mean pain over 72 hours after arthroscopic subacromial decompression surgery compared with vehicle control and improved several measures of postoperative opioid use.


Lead Product(s): Bupivacaine

Therapeutic Area: Neurology Product Name: Posimir

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable July 06, 2022

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

XARACOLL (Bupivacaine HCl), an innovative collagen drug-device implant, 300mg dose cohort experienced less pain and, was generally well tolerated with an adverse event profile comparable to the current prescribing information.


Lead Product(s): Bupivacaine Hydrochloride

Therapeutic Area: Neurology Product Name: Xaracoll

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable March 02, 2022

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

Approved by the US Food and Drug Administration (FDA) in August 2020, XARACOLL is a unique, non-injectable, drug-device combination in the form of a fully bioresorbable collagen implant containing bupivacaine hydrochloride.


Lead Product(s): Bupivacaine Hydrochloride

Therapeutic Area: Neurology Product Name: Xaracoll

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable October 29, 2020

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

US Food and Drug Administration (FDA) has approved Xaracoll® for acute postsurgical pain relief for up to 24 hours in adults following open inguinal hernia repair, a painful and commonly-performed surgery.


Lead Product(s): Bupivacaine Hydrochloride

Therapeutic Area: Neurology Product Name: Xaracoll

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable August 31, 2020

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

If approved, XARACOLL will be Innocoll's first commercially available product in the US.


Lead Product(s): Bupivacaine Hydrochloride

Therapeutic Area: Neurology Product Name: Undisclosed

Highest Development Status: Phase IIIProduct Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable March 26, 2020

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

Innocoll anticipates a 6-month review by the FDA.


Lead Product(s): Bupivacaine Hydrochloride

Therapeutic Area: Neurology Product Name: Undisclosed

Highest Development Status: Phase IIIProduct Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable February 27, 2020

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY